Type to search

Amniotics Receives Approval for Phase I/II Study of Pulmostem™ in Hospitalized COVID-19 Patients | Pharmtech Focus
Amniotics Strengthens its Clinical and Regulatory Capabilities | Pharmtech Focus
Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies | Pharmtech Focus